Get 20% Free Customization In This Report

Buy this report from - $3456

DHA from Algae Market by Type (DHA Powder and DHA Oil); Applications (Infant Formula, Nutritional Supplements, and Food & Beverage); Distribution Network (Convenient Stores, Hypermarkets or Supermarkets, e-Commerce, and Individual Stores); and End User (Consumers, Food Manufacturers, Nutraceutical Manufacturers, Cosmetics Manufacturers, Pharmaceutical Manufacturers, and Animal Feed Manufacturers) - Global Opportunities and Industry Forecasts, 2017-2023

Healthcare	LI_183808	Pages: NA	Jul 2018 \| 644 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

DHA, docosahexaenoic acid, is a fatty acid in fish oils, which is important for the development of the brain in infants. DHA algal oil is manufactured by an algal fermentation process from the marine microalga.

The factors that drive the DHA from algae market include increasing health awareness among consumers, high demand for DHA in infant formula, changing lifestyle, increasing disposable incomes, rapid rate of urbanization, and higher shelf life of DHA. However, high production costs and stringent regulation barriers are likely to hinder the market growth. The development of innovative products by investing in R&D and the increasing number of collaboration among players will foster the market growth in the near future.

The DHA from algae market is segmented on the basis of type, application, distribution network, end-user, and region. Based on product, the market is categorized into DHA powder and DHA oil. By application, the market is segmented into infant formula, nutritional supplements, food & beverage, and others. Based on distribution network, the market is segmented into convenient stores, hypermarkets or supermarket, e-commerce, and individual stores. On the basis of end-user, the market is segmented into consumers, food manufacturers, nutraceutical manufacturers, cosmetics manufacturers, pharmaceutical manufacturers, and animal feed manufacturers. Geographically, it has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Goerlich Pharma, Source Omega LLC, Nordic Naturals, Inc., InovoBiologic Inc., Kangcare Bioindustry Co., Ltd., Deva Nutrition LLC, Xiamen Huison Biotech Co., Ltd., Hubei Ruiren Biotechnology co., Ltd., Wuhan Bioco Sci. & Tech. Dev. Co., Ltd., and Polaris.

Key Benefits

The study provides an in-depth analysis of the global DHA from algae market with current trends and future estimations to elucidate imminent investment pockets.
The report provides information about the current and upcoming trends in the global DHA from algae market from 2016 to 2023, which helps determine prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the growth of the global DHA from algae market has been provided.
Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global DHA from algae market.

DHA From Algae Market Key Segments:

By Type

DHA Powder
DHA Oil

By Application

Infant Formula
Nutritional Supplements
Food & Beverage
Others

By Distribution Network

Convenient Stores
Hypermarkets Or Supermarket
e-Commerce
Individual Stores

By End User

Consumers
Food Manufacturers
Nutraceutical Manufacturers
Cosmetics Manufacturers
Pharmaceutical Manufacturers
Animal Feed Manufacturers

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 DHA FROM ALGAE MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. DHA POWDER

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. DHA OIL

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 DHA FROM ALGAE MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. INFANT FORMULA

5.2.1. Market size and forecast

5.3. NUTRITIONAL SUPPLEMENTS

5.3.1. Market size and forecast

5.4. FOOD & BEVERAGE

5.4.1. Market size and forecast

5.5. OTHERS

5.5.1. Market size and forecast

Chapter: 6 DHA FROM ALGAE MARKET, BY DISTRIBUTION NETWORK

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. CONVENIENT STORES

6.2.1. Market size and forecast

6.3. HYPERMARKETS OR SUPERMARKETS

6.3.1. Market size and forecast

6.4. E-COMMERCE

6.4.1. Market size and forecast

6.5. INDIVIDUAL STORES

6.5.1. Market size and forecast

Chapter: 7 DHA FROM ALGAE MARKET, BY END USER

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. CONSUMERS

7.2.1. Market size and forecast

7.3. FOOD MANUFACTURERS

7.3.1. Market size and forecast

7.4. NUTRACEUTICAL MANUFACTURERS

7.4.1. Market size and forecast

7.5. COSMETICS MANUFACTURERS

7.5.1. Market size and forecast

7.6. PHARMACEUTICAL MANUFACTURERS

7.6.1. Market size and forecast

7.7. ANIMAL FEED MANUFACTURERS

7.7.1. Market size and forecast

Chapter: 8 DHA FROM ALGAE MARKET, BY REGION

8.1. OVERVIEW
8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast

8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast

8.2.4. North America DHA from Algae Market by Type
8.2.5. North America DHA from Algae Market by Application
8.2.6. North America DHA from Algae Market by Distribution Network
8.2.7. North America DHA from Algae Market by End User

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast

8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast

8.3.4. Europe DHA from Algae Market by Type
8.3.5. Europe DHA from Algae Market by Application
8.3.6. Europe DHA from Algae Market by Distribution Network
8.3.7. Europe DHA from Algae Market by End User

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast

8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Rest of Asia-Pacific market size and forecast

8.4.4. Asia-Pacific DHA from Algae Market by Type
8.4.5. Asia-Pacific DHA from Algae Market by Application
8.4.6. Asia-Pacific DHA from Algae Market by Distribution Network
8.4.7. Asia-Pacific DHA from Algae Market by End User

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

8.5.3.1. Brazil market size and forecast
8.5.3.2. Saudi Arabia market size and forecast
8.5.3.3. South Africa market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast

8.5.4. LAMEA DHA from Algae Market by Type
8.5.5. LAMEA DHA from Algae Market by Application
8.5.6. LAMEA DHA from Algae Market by Distribution Network
8.5.7. LAMEA DHA from Algae Market by End User

Chapter: 9 COMPANY PROFILES

9.1. GOERLICH PHARMA

9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments

9.2. SOURCE OMEGA LLC

9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments

9.3. NORDIC NATURALS, INC.

9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments

9.4. INOVOBIOLOGIC INC.

9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments

9.5. KANGCARE BIOINDUSTRY CO., LTD.

9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments

9.6. DEVA NUTRITION LLC

9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments

9.7. XIAMEN HUISON BIOTECH CO., LTD.

9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments

9.8. HUBEI RUIREN BIOTECHNOLOGY CO., LTD

9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments

9.9. WUHAN BIOCO SCI. & TECH. DEV. CO.,LTD.

9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments

9.10. POLARIS

9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty